Europe's industry wants urgent action over "detrimental" effects of price referencing
This article was originally published in Scrip
Executive Summary
The European pharmaceutical industry association, EFPIA, says there is an "urgent need for action" to deal with the "detrimental" problem of international reference pricing, a tool which is used by the bulk of European Union countries (24 out of 27) and which has a downward effect on drug prices.